-
Daniel Ginsberg, MD, FACP
I'm an internal medicine physician and have avidly applied computers to medicine since 1986, when I wrote my first medically oriented computer programs. So yes, that means I'm at least 35-years-old!
Categories
Search Site
-
Recent Posts
- Aspirin – Questioning Established Wisdom
- Medical Pricing Transparency via Non-Transparent Rule
- National Guideline Clearinghouse Goes Kaput
- Fever – Hot Off the Press
- Drawing Lessons From a Disaster
- Wasting Resources – A Day in the Life of Yours Truly
- As If I Have Nothing Better To Do
- Trying to Destroy Healthcare the Ostrich Way
- Regulators Asleep at the Wheel
- Politicians Playing Doctor
- Exploring Cuba – Part 2
- Exploring Cuba – Part 1
- Presidential Politics and Influenza Vaccinations
- ICD-10 Keeps Getting More Painful
- Remote Globe Puppy
- Let’s be Clear on ClariSpray
- Healthy Snacks
- The Medical Paperwork Reduction Act
- Trump the Bureaucracy
- Gluteus Maximus
- Disabled Parking and Needless Paperwork
- An ICD-9 Story
- Going Viral is Bad for Your Health
- Medicare Audits – Or How I Spent Part of Labor Day Weekend
- Asinine Associations
- Sesame Chicken
- A High Tech Call Schedule
- Medicare Payment Formula Finally Changed – Win or Loss?
- Healthy Kitchens, Healthy Lives
- Patient Satisfaction / Physician Dissatisfaction
- January Resolutions
- When is DNR not DNR?
- FMLA Paperwork
- Epic SmartPhrases
- How to Get Rich – A Guide for Pharmaceutical Companies
- Quitting Smoking and Happiness
- If Doctors Ran Their Practice Like The Airlines
- Up in Arms, Up in Smoke
- Humor Down Under
- Who Are You Calling Old?
Monthly Archives: February 2016
Gluteus Maximus
I ordered atorvastatin (generic Lipitor) for one of my patients with high cholesterol and Medicare Part D coverage. It was denied. We then appealed it (prior authorization). A fax from Maximus Federal Services said their decision was, “UNFAVORABLE.” They said … Continue reading
Posted in Government, Pharmaceuticals
Tagged drug, humor, Medicare, medicine, pharmacy, red tape
3 Comments
